Zahra Masoud

Researchers investigated the effects of ILI on pneumococcal carriage in community-dwelling older adults.

Researchers sought to determine the effect of social distancing measures in Dane County, Wisconsin, the Milwaukee metropolitan area, and the New York City metropolitan area.

Study authors identified and evaluated a statistical signal for an increased risk of Guillain-Barré Syndrome in days 1-42 after 2018-2019 high-dose influenza vaccine administration.

SARS-CoV-2’s association with encephalitis was assessed by authors, taking varying clinical presentations, responses to treatment, and outcomes into account.

The effect of appropriate antimicrobial therapy on 14-day mortality in patients severely ill with Acinetobacter baumannii bacteremic pneumonia was assessed, taking risk factors, patient demographics, and clinical characteristics into account.

Study authors assessed the emergence of presatovir-resistant substitutions in the treatment of RSV, and the potential effects on in-vitro susceptibility, viral fitness in replication assays, and outcomes.

Fluticasone/salmeterol and budesonide/formoterol are common treatments for COPD; researchers investigated whether these treatments may be correlated with active tuberculosis risk.

Study authors assessed the association between elevated and increasing red blood cell distribution width and increased mortality risk in patients with COVID-19.

The increased and inadequate use of linezolid prescriptions in a tertiary NICU and growing concerns of antimicrobial resistance are reviewed.

Researchers conducted an observational, prospective, multicentric study to assess the possible relationship between granulocytic markers and COVID-19 infection and severity.

Investigators conducted a randomized, open-label trial during the 2018-2019 influenza season to assess neutralization titers in pre- and post-immunization sera from 133 adults immunized with one of three types of influenza vaccines.

New study published in the European Respiratory Journal suggest that in most settings, the odds of drug resistance are the same for children and adults with TB, consistent with past research.

The use of a PCR test via single nasopharyngeal swab to diagnose SARS-CoV-2 has value but also has demonstrated limitations.

A high through-put Luminex antibody assay may provide more accurate results in less time, increasing the efficiency of SARS-CoV-2 diagnosis.

A case of COVID-19 transmission in a high-rise apartment complex in China demonstrates the probable transmission of SARS-CoV-2 through fecal aerosols.

Considering the impact quarantine has on resources and individual liberty, it is important to evaluate under what conditions individual quarantine can more effectively control COVID-19 than active monitoring.

Icatibant, a bradykinin 2 receptor antagonist, may improve oxygenation in patients with coronavirus disease 2019 (COVID-19).

During the upcoming flu season, it is essential to ensure a high coverage rate of vaccination, particularly among populations who are vulnerable to COVID-19.

Following the initial pandemic wave of SARS-CoV-2 infections, it is unclear what trajectory of transition SARS-CoV-2 might take.

Patients with COVID-19 who are admitted to the ICU may experience higher rates of coinfections requiring antibiotic therapy compared with non-ICU patients.

Critically ill patients hospitalized with COVID-19 — particularly those who develop ARDS — may also experience an opportunistic aspergillosis superinfection.

A shorter regimen of rifampin is safer and less expensive than the standard 9-month regimen of isoniazid for treatment latent tuberculosis.

A team of investigators compared the sensitivity and specificity of 4 enzyme-linked immunosorbent assays and 2 rapid tests in patients with symptomatic SARS-CoV-2 infection.

In response to the COVID-19 pandemic, New York State implemented a series of community mitigation strategies, and monitoring approaches are needed to assess the effect of these interventions.

Elevated lactate dehydrogenase may be a predictive marker of acute respiratory distress syndrome and morality in patients with COVID-19.

Progression in characterizing the symptoms and treatments for infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the subsequent development of coronavirus disease 2019 (COVID-19).

Early neuraminidase inhibitor therapy may result in better outcomes in patients hospitalized with influenza B-related pneumonia.

Anti-methicillin-resistant Staphylococcus aureus (MRSA) therapy in addition to standard pneumonia therapy does not improve mortality.

Compared with patients prescribed only an antiviral, patients who are prescribed both an antiviral and antibiotic have a lower risk for 3-day respiratory hospitalization.

In patients without a contraindication, rifampicin may be the safest treatment option for latent tuberculosis (TB) infection.